Steven Halper
Stock Analyst at Cantor Fitzgerald
(0.07)
# 4,040
Out of 4,667 analysts
72
Total ratings
n/a
Success rate
-14.7%
Average return
Main Sectors:
Stocks Rated by Steven Halper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $11 | $8.10 | +35.80% | 5 | Sep 26, 2023 | |
| NNOX Nano-X Imaging | Reiterates: Overweight | $30 | $6.10 | +391.73% | 11 | Sep 26, 2023 | |
| HCAT Health Catalyst | Reiterates: Overweight | $16 | $7.66 | +108.88% | 4 | Sep 14, 2023 | |
| AMWL American Well | Initiates: Overweight | $300 | $8.02 | +3,640.65% | 1 | Sep 14, 2021 | |
| HQY HealthEquity | Maintains: Overweight | $82 → $85 | $105.08 | -19.11% | 10 | Jun 8, 2021 | |
| OMCL Omnicell | Downgrades: Neutral | n/a | $43.84 | - | 7 | Dec 3, 2020 | |
| ROOT Root, Inc. | Initiates: Overweight | $504 | $110.17 | +357.47% | 1 | Nov 23, 2020 | |
| GOCO GoHealth | Initiates: Overweight | $390 | $11.52 | +3,285.42% | 1 | Aug 10, 2020 | |
| EVH Evolent Health | Downgrades: Neutral | $9 → $8 | $11.49 | -30.37% | 6 | Jun 2, 2020 | |
| TDOC Teladoc Health | Maintains: Neutral | $135 → $145 | $10.23 | +1,318.09% | 8 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $150 → $185 | $5.08 | +3,541.73% | 5 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $245 → $255 | $328.86 | -22.46% | 2 | Feb 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $345 → $400 | $295.03 | +35.58% | 2 | Feb 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $32 | $19.00 | +68.42% | 1 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $83 | $59.83 | +37.89% | 8 | Dec 17, 2018 |
Nyxoah
Sep 26, 2023
Reiterates: Overweight
Price Target: $11
Current: $8.10
Upside: +35.80%
Nano-X Imaging
Sep 26, 2023
Reiterates: Overweight
Price Target: $30
Current: $6.10
Upside: +391.73%
Health Catalyst
Sep 14, 2023
Reiterates: Overweight
Price Target: $16
Current: $7.66
Upside: +108.88%
American Well
Sep 14, 2021
Initiates: Overweight
Price Target: $300
Current: $8.02
Upside: +3,640.65%
HealthEquity
Jun 8, 2021
Maintains: Overweight
Price Target: $82 → $85
Current: $105.08
Upside: -19.11%
Omnicell
Dec 3, 2020
Downgrades: Neutral
Price Target: n/a
Current: $43.84
Upside: -
Root, Inc.
Nov 23, 2020
Initiates: Overweight
Price Target: $504
Current: $110.17
Upside: +357.47%
GoHealth
Aug 10, 2020
Initiates: Overweight
Price Target: $390
Current: $11.52
Upside: +3,285.42%
Evolent Health
Jun 2, 2020
Downgrades: Neutral
Price Target: $9 → $8
Current: $11.49
Upside: -30.37%
Teladoc Health
Apr 15, 2020
Maintains: Neutral
Price Target: $135 → $145
Current: $10.23
Upside: +1,318.09%
Feb 21, 2020
Reiterates: Overweight
Price Target: $150 → $185
Current: $5.08
Upside: +3,541.73%
Feb 6, 2020
Reiterates: Overweight
Price Target: $245 → $255
Current: $328.86
Upside: -22.46%
Feb 5, 2020
Reiterates: Overweight
Price Target: $345 → $400
Current: $295.03
Upside: +35.58%
Jan 9, 2020
Initiates: Overweight
Price Target: $32
Current: $19.00
Upside: +68.42%
Dec 17, 2018
Maintains: Overweight
Price Target: $73 → $83
Current: $59.83
Upside: +37.89%